Immuron (IMRN) Cash from Operations (2016 - 2024)
Immuron (IMRN) posted quarterly Cash from Operations of 2820226.31 for Q4 2024, down 40.74% year-on-year from 4759182.73 in Q1 2024, and down 40.74% on a QoQ basis from 2003836.0 in Q4 2023.
Immuron (IMRN) Cash from Operations (2016 - 2024) Analysis & Trends
Immuron (IMRN) has reported Cash from Operations for 9 consecutive years, with 2820226.31 the latest figure, recorded in Q4 2024.
- Quarterly Cash from Operations fell 40.74% year-over-year to 2820226.31 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 7648870.05 (down 8.47% YoY) and the FY2025 annual result came in at 6136949.0, down 4.37% from the prior year.
- Cash from Operations retreated to 2820226.31 in Q4 2024 per IMRN's latest filing, from 2003836.0 in the prior quarter.
- Over the last five years, Cash from Operations for IMRN reached as high as 1427.28 in Q4 2021 and fell as low as 2880511.77 in Q2 2021.
- A 5-year average of 1964792.15 and a median of 2222720.69 in 2020 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2021 — Cash from Operations soared 100.05% — and 2022, when it slumped 69604.02%.
- Year by year, Cash from Operations stood at 2709405.0 in 2020, then surged by 100.05% to 1427.28 in 2021, then sank by 69604.02% to 992017.0 in 2022, then tumbled by 102.0% to 2003836.0 in 2023, then tumbled by 40.74% to 2820226.31 in 2024.
- According to Business Quant data, Cash from Operations over the past three periods registered 2820226.31, 2003836.0, and 1832790.74 for Q4 2024, Q4 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.82 Mn |
| Dec 31, 2024 | -2.82 Mn |
| Dec 31, 2023 | -2.00 Mn |
| Dec 31, 2023 | -2.00 Mn |
| Jun 30, 2023 | -1.83 Mn |
| Jun 30, 2023 | -1.83 Mn |
| Dec 31, 2022 | -992,017.00 |
| Dec 31, 2022 | -992,017.00 |
| Jun 30, 2022 | -2.22 Mn |
| Jun 30, 2022 | -2.22 Mn |
| Dec 31, 2021 | 1,427.28 |
| Dec 31, 2021 | 1,427.28 |
| Jun 30, 2021 | -2.88 Mn |
| Jun 30, 2021 | -2.88 Mn |
| Dec 31, 2020 | -2.71 Mn |
| Dec 31, 2020 | -2.71 Mn |
| Jun 30, 2020 | -2.22 Mn |
| Jun 30, 2020 | -2.22 Mn |
| Dec 31, 2019 | -1.56 Mn |
| Dec 31, 2019 | -1.56 Mn |